Results 141 to 150 of about 268,545 (217)

Characteristics of endometrial cancer progressed to extrauterine lesions following fertility preserving medroxyprogesterone acetate therapy for young endometrial cancer patients. [PDF]

J Gynecol Oncol
Kitazawa S, Sakai K, Kawaida M, Chiyoda T, Nishio H, Banno K, Susumu N, Yamagami W.   +7 more
europepmc   +1 more source

The effects of transdermal estrogens combined with Medroxyprogesterone Acetate on cardiovascular disease risk factors in postmenopausal women: a meta-analysis of randomized controlled trials. [PDF]

Diabetol Metab Syndr
Zhou F, Prabahar K, Shu J.
europepmc   +1 more source

Cardiometabolic Risk Marker Changes in Centrally Obese Women Using Depot Medroxyprogesterone Acetate (DMPA) in Kigali, Rwanda. [PDF]

Rwanda J Med Health Sci
Kantarama E, Uwizeye D, Uwineza A.
europepmc   +1 more source

Understanding the Acceptability of Depot Medroxyprogesterone Acetate (ANTARA) among Women of Reproductive Age from the Lens of Grassroot Level Providers in Rural and Urban Areas of Nagpur, India. [PDF]

Ann Afr Med
Lakshmi NRA, Dani A, Vithalani NJ, Ramasamy N, Dongre AR, Vijayageetha M.   +5 more
europepmc   +1 more source

Safety evaluation of medroxyprogesterone acetate: a pharmacovigilance analysis using FDA adverse event reporting system data. [PDF]

Front Pharmacol
Su L, Xu R, Ren Y, Zhao S, Liu W, Du Z.
europepmc   +1 more source

Contraceptive method continuation among a prospective cohort study of Malawian women on antiretroviral treatment initiating the Levonorgestrel Implant or the Depot Medroxyprogesterone Acetate Injectable for pregnancy prevention (the FP-ART study). [PDF]

AIDS Care
Hagey J, Liu X, Mollan K, Diepstra K, Lemani C, Chapola J, Bula A, Winston J, Chinula L, Hosseinipour M, Phiri S, Appiagyei A, Hudgens M, Tang JH.   +13 more
europepmc   +1 more source

Depot medroxyprogesterone acetate concentrations in patients with and without the use of antiseizure medications. [PDF]

Contraception
Dutton C, Mody SK, Nippita S, Dodge LE, Pang T, Pennell PB, Davis A.   +6 more
europepmc   +1 more source

Polyphyllin VII enhances the sensitivity of endometrial carcinoma cells to medroxyprogesterone acetate through upregulating miR‑33a‑5p expression. [PDF]

Oncol Lett
Liu H, Peng Y, Zhuang X.
europepmc   +1 more source

Retraction Note: The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial. [PDF]

Reprod Health
Guo H, Du T, Gao H, Xi Q, Wu L, Lyu Q, Zhu Q.   +6 more
europepmc   +1 more source